Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Arcadia Biosciences, Inc. (RKDA) had Normalized Income after Taxes of $-4.38M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$1.10M |
|
$-4.38M |
|
$0.70M |
|
$0.40M |
|
$1.88M |
|
$-0.78M |
|
$-3.61M |
|
$-4.38M |
|
$-4.38M |
|
$-4.38M |
|
$-4.38M |
|
$-4.38M |
|
|
Normalized Income after Taxes |
$-4.38M |
$-0.78M |
|
$-0.77M |
|
2.08M |
|
2.08M |
|
$-2.11 |
|
$-2.11 |
|
| Balance Sheet Financials | |
$5.17M |
|
-- |
|
$0.15M |
|
$5.32M |
|
$1.36M |
|
-- |
|
$1.07M |
|
$2.44M |
|
$2.88M |
|
$2.85M |
|
$2.88M |
|
2.06M |
|
| Cash Flow Statement Financials | |
$-1.10M |
|
-- |
|
$1.79M |
|
$0.26M |
|
$0.95M |
|
$0.69M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
36.36% |
|
-70.82% |
|
-70.82% |
|
-- |
|
-398.64% |
|
-398.64% |
|
$-1.10M |
|
-- |
|
-- |
|
-- |
|
0.21 |
|
0.83 |
|
2.59 |
|
34.77 |
|
-151.99% |
|
-154.08% |
|
-82.38% |
|
-151.99% |
|
$1.40 |
|
$-0.53 |
|
$-0.53 |
|